Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
20 authors.
Gaoussou SanouIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0003-2204-2466
Guilhem ZeitounIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0009-0002-6742-1646
Taciana MansoIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0001-9787-0640
Milad EidiIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0001-5582-4435
Shamsa BatoolIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0009-0005-3806-3810
Anjana KushwahaIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0009-0002-9046-9584
François GrandIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0009-0009-5460-8015
Myriam CrozeIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0003-2164-1395
Axel VaillantIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0009-0005-7469-4150
Chahrazed DebbaghIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0002-4594-617X
Nika AbdollahiIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0003-2618-4760
Maria GeorgaIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0002-3969-7437
Ariadni PapadakiIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0001-6497-032X
Ifigeneia SideriIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0001-9986-7904
Turkan SamadovaIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0009-0004-1599-1334
Joumana Jabado-MichaloudIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0003-4291-2027
Géraldine FolchIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0002-5677-5193
Véronique GiudicelliIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0002-2258-468X
Patrice DurouxIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0001-8935-7900
Sofia KossidaIMGT®, the international ImMunoGeneTics Information System®, Institute of Human Genetics, University of Montpellier, Scientific Research National Center (CNRS), Montpellier, France.ORCID 0000-0003-2482-0022
Funding
GENCIImmun4Cure University Hospital Institute "Institute for innovative immunotherapies in autoimmune diseases" 2030 / ANR-23-IHUA-0009Institut du développement et des ressources en informatique scientifique (IDRIS) 036029Institut Universitaire de FranceScientific Research National Center (CNRS)University of Montpellier
6 · The paper itself
Abstract
IMGT®, the international ImMunoGeneTics information system®, has advanced its comprehensive platform for the analysis of immunoglobulin (IG) and T-cell receptor (TR) genes through the development of new automated and scalable tools. This article presents major updates aligned with IMGT's three axes of research. Axis I introduces dynamic resources such as IMGT/GeneTables, IMGT/AssemblyComparison, IMGT/CDRLengths, IMGT/MultiGenomeViewer, enabling real-time access to annotated genomic data, and IMGT/StatAssembly to assess quality of IG/TR loci in assemblies. Axis II enhances repertoire analysis with a redesigned IMGT/GeneFrequency tool and new customization features in IMGT/V-QUEST, supporting flexible exploration of IG and TR gene expression. Axis III improves the accurate prediction of peptide-MHC thanks to IMGT/RobustpMHC. Additionally, the IMGT knowledge graph and its therapeutic extension, IMGT/mAb-KG, provide semantically structured access to >100 million immunogenetic triplets, integrating IMGT databases and linking IMGT content to external biomedical resources. These developments promote standardization, interoperability, and integrative analysis across immunogenetics and clinical applications, reinforcing IMGT's (accessible at https://www.imgt.org) role as a core reference in the era of FAIR data and personalized medicine.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
IMGT® at scale: FAIR, dynamic, and automated tools for immune locus analysis. · full record | OpenQuestion